BioCentury
ARTICLE | Company News

Maxygen, Eli Lilly deal

January 6, 2003 8:00 AM UTC

MAXY subsidiary Codexis Inc. (Redwood City, Calif.) will develop improved fermentations for several LLY natural product drugs. Codexis will receive an upfront technology access fee and full research ...